Skip to content

Jobs updated Oct 23, 6:25 AM CT

COMPANY

Yaso Therapeutics Corporation

yasotherapeutics.com ↗

Clinical Phase 1

Also known as Yaso Therapeutics · 2 sources

Profile checked Oct 10, 2026

Keywords: Early-phase Safety and PK Study of a Vaginal Gel

1Trials (company is sponsor)

Timeline

2026-04 Trial start 1: FIH Lead-in Study of YASO GEL Followed by a Phase 1 Randomized, Double-blind Study to Assess Safety and Pharmacokinetics of YASO GEL source ↗
Sep 11, 2025 Grant Government grant — SBIR: $545,966 (annual award, as published), announced Sep 11, 2025. Agency: NIH/NICHD. Source: government award database. source ↗

Upcoming milestones

2028-02 (ESTIMATED) · 1 · FIH Lead-in Study of YASO GEL Followed by a Phase 1 Randomized, Double-blind Study to Assess Safety and Pharmacokinetics of YASO GEL · NCT07281404

Estimated primary completion per ClinicalTrials.gov. Dates move.

Funding

Last 2 years.

Sep 11, 2025 Government grant — SBIR: $545,966 (annual award, as published), announced Sep 11, 2025. Agency: NIH/NICHD. Source: government award database. source ↗

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT07281404	FIH Lead-in Study of YASO GEL Followed by a Phase 1 Randomized, Double-blind Study to Assess Safety and Pharmacokinetics of YASO GEL	1	Not yet recruiting	2026-04	2028-02 (estimated)